Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Bullboard Posts
Comment by MineDiggeron Sep 04, 2012 3:21am
173 Views
Post# 20313577

RE: RE: Wishing for guidance! How others do it...

RE: RE: Wishing for guidance! How others do it...

I'm talking about exactly what I'm talking about, which is insight/hints into how the management sees themselves by way say of comparison with other others that they consider financially equivalently valued, rather than how we try to value a piecemeal picture of bits and pieces of published information and without (well in my case, not sure about you) direct long-term relevent managerial experience and guidance from experts in the field (and of course ongoing results).

And also, the company in question has made a specific statement about selling itself in due course, an exit strategy always helps reduce uncertainty and thus presumably increases value. Unfortunately the way this valuation "projection" has come about is slightly tenuous (a reference to a 2011 M&A deal in a presentation, without a specific written comment about it being a reasonable comparison, but also without any knowledge of what has been said to accompany the presentation).

I'm not saying we're not worth a lot more, just I'd like a hint from the company as to where they see themselves. And in fact, given the hint in the BTV promo, we should be in the middle of the "really exciting time, for us, .... and shareholders", I'm not seeing that yet.

Bullboard Posts